Marten Steen - 18 May 2021 Form 4 Insider Report for Strongbridge Biopharma plc

Role
Director
Signature
/s/ Judith Goldberg, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
18 May 2021
Net transactions value
$0
Form type
4
Filing time
18 May 2021, 19:14:48 UTC
Previous filing
18 May 2021
Next filing
05 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SBBP Ordinary Shares Award $0 +40,000 +95% $0.000000 81,914 18 May 2021 By HealthCap VI, L.P. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units, which vest in full on May 18, 2022, provided that the Reporting Person continues to serve as a member of the board of directors of the Issuer through that date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 Based on his affiliation with HealthCap VI, L.P., the Reporting Person may be deemed the beneficial owner of these securities. The Reporting Person expressly disclaims beneficial ownership over these securities except to the extent of his pecuniary interest therein.